Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-25-016039
Filing Date
2025-01-30
Accepted
2025-01-30 06:57:41
Documents
24

Document Format Files

Seq Description Document Type Size
1 S-1/A d769642ds1a.htm S-1/A 2261439
2 EX-5.1 d769642dex51.htm EX-5.1 11811
3 EX-10.16 d769642dex1016.htm EX-10.16 12747
4 EX-23.1 d769642dex231.htm EX-23.1 1488
5 GRAPHIC g769642g01a13.jpg GRAPHIC 136435
6 GRAPHIC g769642g02g02.jpg GRAPHIC 216927
7 GRAPHIC g769642g05f43.jpg GRAPHIC 601719
8 GRAPHIC g769642g13a01.jpg GRAPHIC 157666
9 GRAPHIC g769642g21j92.jpg GRAPHIC 2841
10 GRAPHIC g769642g30x67.jpg GRAPHIC 36350
11 GRAPHIC g769642g31l38.jpg GRAPHIC 116948
12 GRAPHIC g769642g55f74.jpg GRAPHIC 58099
13 GRAPHIC g769642g62f25.jpg GRAPHIC 64074
14 GRAPHIC g769642g66t55.jpg GRAPHIC 32846
15 GRAPHIC g769642g72h13.jpg GRAPHIC 35890
16 GRAPHIC g769642g72u41.jpg GRAPHIC 29072
17 GRAPHIC g769642g74a05.jpg GRAPHIC 122445
18 GRAPHIC g769642g76l04.jpg GRAPHIC 54832
19 GRAPHIC g769642g77q77.jpg GRAPHIC 33838
20 GRAPHIC g769642g81q05.jpg GRAPHIC 40409
21 GRAPHIC g769642g94f07.jpg GRAPHIC 110517
22 GRAPHIC g769642g96l94.jpg GRAPHIC 67135
23 GRAPHIC g769642g98g45.jpg GRAPHIC 43304
24 GRAPHIC g769642g98o36.jpg GRAPHIC 31282
  Complete submission text file 0001193125-25-016039.txt   5007335
Mailing Address 171 OYSTER POINT BOULEVARD, SUITE 300 SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BOULEVARD, SUITE 300 SAN FRANCISCO CA 94080 6508505070
Maze Therapeutics, Inc. (Filer) CIK: 0001842295 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-284164 | Film No.: 25571139
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)